Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma

References

• Abramson DH. Retinoblastoma: saving life with vision. Annu Rev Med 2014;65:171–184.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth Group Vb retinoblastoma. Arch Ophthalmol 2004;122:1316–1323.
   PubMedGoogle Scholar
• Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004;24:828–848.
   PubMed Web of Science ®Google Scholar
• Chan H, Gallie B, Munier F, Beckpopovic M. Chemotherapy for retinoblastoma. Ophthalmol Clin N Am 2005;18:55–63.
   PubMedGoogle Scholar
• Chung SE, Sa HS, Koo HH, et al. Clinical manifestations and treatment of retinoblastoma in Korea. Br J Ophthalmol 2008;92:1180–1184.
   PubMed Web of Science ®Google Scholar
• Gündüz K, Köse K, Kurt RA, et al. Retinoblastoma in Turkey: results from a tertiary care center in Ankara. J Pediatr Ophthalmol Strabismus 2013;50:296–303.
   PubMed Web of Science ®Google Scholar
• Lim FPM, Soh SY, Iyer JV, et al. Clinical profile, management, and outcome of retinoblastoma in Singapore. J Pediatr Ophthalmol Strabismus 2012;50:106–112.
   PubMed Web of Science ®Google Scholar
• Mallipatna AC, Sutherland JE, Gallie BL, et al. Management and outcome of unilateral retinoblastoma. J Am Assoc Pediatr Ophthalmol Strabismus 2009;13:546–550.
   Web of Science ®Google Scholar
• Reese AB, Hyman GA, Merriam GR, et al. Treatment of retinoblastoma by radiation and triethylenemelamine. AMA Arch Ophthalmol 1954;53:505–513.
   PubMed Web of Science ®Google Scholar
• Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 2004;9:69–73.
   PubMedGoogle Scholar
• Abramson DH, Dunkel IJ, Brodie SE, et al. A Phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma. Ophthalmology 2008;115:1398–1404.e1.
   PubMed Web of Science ®Google Scholar
• Abramson DH. Chemosurgery for retinoblastoma. Arch Ophthalmol 2011;129:1492–1494.
   PubMedGoogle Scholar
• Chantada G, Schaiquevich P. Management of retinoblastoma in children: current status. Pediatr Drugs 2015;17:185–198.
   PubMed Web of Science ®Google Scholar
• Shields CL, Kaliki S, Shah SU, et al. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment. Retina (Philadelphia, PA) 2012;32:799–804.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Marr BP, Brodie SE, et al. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. Abramson DH, Marr BP, Brodie SE, et al., eds. PLoS One 2012;7(4):e34120.
   Google Scholar
• Muen WJ, Kingston JE, Robertson F, et al. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Ophthalmology 2012;119:611–616.
   PubMed Web of Science ®Google Scholar
• Gobin YP, Dunkel IJ, Marr BP, et al. Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma. Gobin YP, Dunkel IJ, Marr BP, et al., eds. PLoS One 2012;7(9):e44322.
   Google Scholar
• Jabbour P, Chalouhi N, Tjoumakaris S, et al. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr 2012;10:175–181.
   PubMed Web of Science ®Google Scholar
• Yousef YA, Soliman SE, Astudillo PPP, et al. Intra-arterial chemotherapy for retinoblastoma: a systematic review. JAMA Ophthalmol 2016;134:584–591.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Shields CL, Munier FL, et al. Treatment of retinoblastoma in 2015. JAMA Ophthalmol 2015;133(11):1341–1347.
   PubMed Web of Science ®Google Scholar
• Lin P, O’Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol 2009;148:192–198.
   PubMed Web of Science ®Google Scholar
• Shields CL, Manjandavida FP, Lally SE, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes. Ophthalmology 2014;121:1453–1460.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Marr BP, Francis JH, et al. Simultaneous bilateral ophthalmic artery chemosurgery for bilateral retinoblastoma (tandem therapy). Vavvas DG, ed. PLoS One 2016;11:e0156806.
   Google Scholar
• Francis JH, Abramson DH, Gaillard M-C, et al. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan. Ophthalmology 2015;122:1173–1179.
   PubMed Web of Science ®Google Scholar
• Francis JH, Abramson DH, Gobin YP, et al. Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review. Cinti C, ed. PLoS One 2014;9:e84247.
   PubMed Web of Science ®Google Scholar
• Francis JH, Abramson DH, Gobin YP, et al. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma. Ophthalmology 2015;122:1016–1022.
   PubMed Web of Science ®Google Scholar
• Francis JH, Schaiquevich P, Buitrago E, et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma. Ophthalmology 2014;121:1810–1817.
   PubMed Web of Science ®Google Scholar
• Abramson DH, Fabius AWM, Issa R, et al. Advanced unilateral retinoblastoma: the impact of ophthalmic artery chemosurgery on enucleation rate and patient survival at MSKCC. Vavvas D, ed. PLoS One 2015;10:e0145436.
   Google Scholar
• Wong JR, Morton LM, Tucker MA, et al. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. J Clin Oncol 2014;32:3284–3290.
   PubMed Web of Science ®Google Scholar
• Tuncer S, Sencer S, Kebudi R, et al. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey. Acta Ophthalmol 2016;94(7):e644–e651.
   Google Scholar
• Ramasubramanian A, Shields CL. Retinoblastoma. New Delhi: JP Medical Ltd; 2012.
   Google Scholar
• de Jong MC, Kors WA, de Graaf P, et al. The incidence of trilateral retinoblastoma: a systematic review and meta-analysis. Am J Ophthalmol 2015;160:1116–1126.e5.
   Google Scholar
• de Jong MC, Kors WA, de Graaf P, et al. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol 2014;15:1157–1167.
   PubMed Web of Science ®Google Scholar